Abstract -The purpose of this study was to assess the test-retest stability of the FagerStrom Tolerance Questionnaire (FTQ) in two samples: (a) paid subjects in an American laboratory; data were collected via telephone screen and subsequently via questions embedded in a written history; and (b) smokers hospitalized for depression in Paris: data were collected via a written questionnaire upon admission and again after 3 weeks of treatment for depression.
What has come to be known as the Fagerstrom Tolerance Questionnaire (FTQ; Fagerstrom, 1978) was presented by the author as a test of "physical dependence to nicotine." Although he reported validation of his instrument in small samples using as his touchstones change in body temperature following withdrawal in smokers and heart rate increment during smoking in both smokers and exsmokers, it is probably safe to say that the widespread use that followed, in both research and clinical settings, was due less to its superior psychometric properties than to the fact that it filled a "market niche," at a time when the importance of nicotine dependence as an obstacle to quitting was becoming increasingly apparent and when pharmacotherapeutic approaches were starting to be developed. Its only "competitors" were questionnaires such as the Reasons for Smoking Scale (Ikard & Tomkins, 1973; Tomkins, 1966) and the Classification of Smoking by Motives (CSM; Russell, Peto, & Patel, 1974) , which were intended to categorize smokers -or more accurately, smoking behavior -on the basis of smoking motivation typology. Though some of the types discriminated (e.g., the CSM "addictive" smoking; Russell et al., 1974 ) might be thought of as tapping a similar construct, these scales, unlike the FTQ, were not explicitly intended to provide a continuum along which u/l smokers could be placed.
Testing of the psychometric properties of the instrument has thus proceeded haphazardly, rather than systematically in different subject samples. Conspicuously lacking, for example, has been any attempt to establish the reliability of the scale. upon admission and again after 3 weeks of treatment for depression. Subjects in both samples were regular smokers who were not attempting to quit and who were not in treatment for smoking cessation. Reliability data are also presented for the FTND and compared with FTQ data collected in a subsample of 60 subjects in the American database who received both versions of the questionnaire. Analyses of internal consistency, using Cronbach's alpha, and external validity, using years smoked (associated with increases in intake: Russell. 1979 ). cotinine (a nicotine metabolitc that serves as a biological index of intake), and scores on the CSM "addictive'* factor (Russell et al., 1974) as criterion variables, are reported briefly.
Subjects were drawn from two separate samples: (a) 237 smokers (43.5% female; age [M ? SD], 28.9 t 6.6 years), in good health (including no history of psychopathology) and not on psychoactive medications, who were paid to participate in experiments in our laboratory between 1986 and the present. A subsample of 60 smokers (25.0% female; age 28.7 2 6.6 years) received the FTND as well. Although subject selection criteria varied across experiments. most were recruited for being moderate smokers who smoked at least I.5 cigarettes per day and who had smoked for at least 3 years, and for being in the 20 to 45 age range. (b) 36 smokers (66.7% female: age 36.3 2 9.6 years) meeting the DSM-III-R criteria of major depression, hospitalized in the Salpetriere Hospital (Paris).
For the American laboratory sample. test-retest data were collected initially via telephone screen and subsequently (15.0 +-31.3 days later) via questions embedded in a written history.
More recently, sufficient data have been collected to permit calculation of scores for both the FTQ and the FTND. Also available for many of Reliability of the FTQ and the FTND 35 these subjects were baseline cotinine levels assayed using HPLC (Hariharan, VanNoord, & Greden, 1988) , number of years smoked, and scores on the "addictive" scale of a brief version of the CSM (Russell et al., 1974) 1970) . (Data were drawn from a database including baseline and demographic variables collected at screening or via take-home packets. Because these packets varied somewhat depending on the study and the time at which they were collected, data for some of the variables included as validators
were not available for all subjects.) For the French sample, the FTQ was filled out as part of a battery of questionnaires administered in the context of a study of smoking behavior in depressed subjects. Each subject was assessed upon admission, before administration of antidepressant treatment and in some instances after a placebo wash-out period. An extensive psychiatric interview, including the Hamilton Rating Scale for Depression (HRSD; Hamilton, 1967) , was conducted by an experienced clinician in order to evaluate intensity of symptomatology, following which patients were asked to complete the questionnaires.
Subjects were reassessed just prior to discharge, when they were judged as normothymic by the clinicians, after at least 3 weeks' antidepressant treatment;
for the majority, assessment was made on Day 21. The procedure was identical to that at Day 0. The CSM was also administered;
for comparability across the two samples, only the three items administered to the American sample were used.
Validity data are presented only for the telephone screen data in the American sample and for the admission interview for the French sample. Results in both instances were similar for the second administration.
RESULTS

FTQ
Test-retest correlations for the two samples, for both the full questionnaire and the individual items, are shown in Table I . No decrease in test-retest reliability was observed as a function of time elapsed between the two administrations in the American sample, as determined by correlating the absolute difference between the two scores with the amount of time between administration (n = 196; I' = -.lO, NS). In the American sample, there was a small but statistically significant decrease (t[236] = 5.23, p < .OOl) in FTQ scores between Time 1 (telephone screen; 7.3 ? 1.8) and Time 2 (written history; 6.9 5 2.0). Individual items that contributed significantly to this drop were item 1 (time to first cigarette), item 2 (forbidden cigarettes), item 3 (which cigarette would you most hate to give up?), and item 6 (smoke if ill). In the French sample, scores on the first administration (5.75 ? 2.3) did not differ significantly from scores on the second (6 ? 2.5), nor did any item score differ significantly between administrations. Cronbach's alpha for our laboratory subjects has been previously reported (Pomerleau et al., 1990) et al., 1990) . This correlation has been sustained with the addition of more subjects to our database (n = 136: r = + .35, p < .OOl). Correlation with number of years smoked (1) = 214) was +.3X (p < .OOl). Scores on the CSM "addictive" factor were significantly correlated with FTQ in both the American sample (n = 216: I' = +.40. p < .OOl) and in the French sample (n = 35; r = t.62, p < ,001).
In the American sample (n = 183), no correlation was detected between CES-D and FTQ scores (r = +.02, NS). Likewise.
in the French sample, no association was detected between FTQ score and severity of depression as measured by the HRSD (r = -.03. NS).
FTND
Test-retest correlations for both the FTQ and the FTND. in the subsample of 60 who took both questionnaires, are shown in Table 2 . There was no significant difference between the first and second administration for either the FTQ (M ? SLI for first administration, 6.9 t 2.2; for second administration, 6.7 -C 2.1; t 1591 = .X3, NS) or the FTND (first administration, 5.3 * 2.4: second administration, 5.1 + 2.4: t [59] = 1.44, NS).
Cronbach's alpha was .58 for the FTQ and .64 for the FTND. Correlation with cotininc (n = 27) was +.4S (p < .OS) for the FTQ and +.39 (p < .05) for the FTND. Correlation with number of years smoked was + .S7 (p < ,001) for the FTQ and + .52 (p < .OOl) for the FTND. Correlation with the CSM "addictive" factor (n = 55) was +.S6 (p < .OOl) for the FTQ and +.S3 (p < ,001) for the FTND. No relationship with depression (n = 59) was detected for either the FTQ (r = -.18, NS) or the FTND (r = -.24. NS).
D I S C U S S 1 0 N
In both the American and French samples. the FTQ showed very satisfactory test-retest reliability.
A high correlation emerged in the American sample despite the use of alternate forms (telephone vs. paper-and-pencil), which might be expected to attenuate the association. Individual items were also well-correlated. In a society in which smoking is not seriously discouraged, one would expect considerably more "discretionary" smoking than in a society characterized by extensive public health campaigns and social sanctions.
Our findings thus suggest that the FTQ is potentially useful in a broad spectrum of populations. A small but consistent decrease in score between the first and second administration occurred in the American, but not in the French, sample. A possible explanation is that, because our subjects were recruited for being moderately dependent, the change simply represents regression to the mean. It is also possible, however, that the use of alternate forms influenced test results. Although the nature of the relationship between depression and degree of dependence remains to be delineated, our results suggest that treatment of depression does not affect the reliability of the FTQ. Test-retest reliability of the FTND was as good as or better than that of the FTQ. We likewise replicated Heatherton et al.'s (1991) results showing a somewhat higher Cronbach's alpha in the FTND than in the FTQ when calculated in the same group of subjects. Our rough measures of external validity, however, did not demonstrate any clearcut superiority for the FTND in this relatively small sample. It should be noted that one of the problems relating to validation of either the FTQ or the FTND is the lack of either "hard" (biological) measures of dependence or a universally agreed-upon set of criteria that would allow us, say, to comment on the sensitivity and specificity of the test, or to establish cutoffs for what Shiffman (e.g., 1990 ) has referred to as nondependent smokers. In fact, we may be demanding more of the test, in terms of internal consistency and construct validity, than we demand of the concept of "physical dependence" itself -because there is no clearcut evidence that chronic tolerance (both pharmacokinetic and pharmacodynamic), acute
